Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0226-2024

Drug recall · December 6, 2023

Kuka Flex Forte caplets recall

Why: Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265

Lots / codes

All lots, exp 12/12/2024

Quantity
300 bottles
Company
Botanical Be, El Paso, TX
Distribution
USA Nationwide
Initiated
October 20, 2023 · Voluntary: Firm initiated
Classified
January 12, 2024
Reported
December 6, 2023
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.